Carelabs Co.Ltd (263700) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Carelabs Co.Ltd (263700) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.10 Billion ≈ $-1.42 Million USD) by net assets (₩78.32 Billion ≈ $53.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Carelabs Co.Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Carelabs Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 263700 current and long-term liabilities for a breakdown of total debt and financial obligations.
Carelabs Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carelabs Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Westport Fuel Systems Inc
TO:WPRT
|
0.007x |
|
TNR Gold Corp.
V:TNR
|
-1.253x |
|
Dabomb Protein
TWO:6578
|
-0.013x |
|
Display Tech Co. Ltd
KQ:066670
|
0.068x |
|
Nam Hwa Construction Co.Ltd
KQ:091590
|
-0.020x |
|
Apollomics Inc. Class A Ordinary Shares
NASDAQ:APLM
|
2.900x |
|
Digitalx Ltd
AU:DCC
|
-0.023x |
|
HWA AG
F:H9W
|
-0.099x |
Annual Cash Flow Conversion Efficiency for Carelabs Co.Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Carelabs Co.Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 263700 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩48.44 Billion ≈ $32.83 Million |
₩-1.89 Billion ≈ $-1.28 Million |
-0.039x | +74.84% |
| 2023-12-31 | ₩68.53 Billion ≈ $46.44 Million |
₩-10.62 Billion ≈ $-7.20 Million |
-0.155x | -110.11% |
| 2022-12-31 | ₩84.61 Billion ≈ $57.34 Million |
₩-6.24 Billion ≈ $-4.23 Million |
-0.074x | -275.57% |
| 2021-12-31 | ₩102.30 Billion ≈ $69.33 Million |
₩4.30 Billion ≈ $2.91 Million |
0.042x | -63.55% |
| 2020-12-31 | ₩98.05 Billion ≈ $66.45 Million |
₩11.30 Billion ≈ $7.66 Million |
0.115x | +61.05% |
| 2019-12-31 | ₩62.25 Billion ≈ $42.19 Million |
₩4.46 Billion ≈ $3.02 Million |
0.072x | +18.76% |
| 2018-12-31 | ₩59.74 Billion ≈ $40.49 Million |
₩3.60 Billion ≈ $2.44 Million |
0.060x | -51.61% |
| 2017-12-31 | ₩23.47 Billion ≈ $15.90 Million |
₩2.92 Billion ≈ $1.98 Million |
0.125x | -50.78% |
| 2016-12-31 | ₩10.40 Billion ≈ $7.05 Million |
₩2.63 Billion ≈ $1.78 Million |
0.253x | -- |
About Carelabs Co.Ltd
Carelabs Co.,Ltd operates as a healthcare and beauty care platform company in South Korea. The company offers healthcare IT services, such as hospital information services, hospital customer management software, and digital marketing solutions. It provides BABITALK, a plastic surgery information platform; Medijob, which provides human resources to hospitals; VIBE RC, a digital marketing platform;… Read more